In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Gilead Sciences, Inc. is one of them. Gilead Sciences, Inc. (NASDAQ:GILD), headquartered in Foster City, California, continues to lead in antiviral and oncology therapies while advancing next-generation biologics through AI integration. Under CEO Daniel O’Day, the company is focusing on precision medicine and translational science to accelerate development and global patient access. In September 2025, Gilead Sci ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to expand its mRNA vaccine and specialty medicine portfolio while maintaining focus on oncology, immunology, and infectious diseases. The company, widely recognized for its COVID-19 vaccine collaboration with BioNTech, recently announced significant progress with its LP.8.1-adapted COMIRNATY 2025-2026 formula. In early ...

For the homeowner who has been waiting for interest rates to come down before refinancing, it can feel like a frustrating time. If you can’t — or don’t want to — wait, tapping your home equity may be a viable alternative. Learn More: 6 Hidden Costs of Homeownership That Can Wreck Your Budget Find Out: 3 Advanced Investing Moves Experts Use to Minimize Taxes and Help Boost Returns “For homeowners who have built up significant equity, a cash-out refinance may be your best option,” said Scott Bridges, chief ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. AbbVie Inc. stands second among them. AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical leader known for therapies across immunology, oncology, and neuroscience, recently secured a major development for its immunology portfolio. On September 11, 2025, the company announced a settlement with all generic manufacturers challenging Rinvoq (upadacitinib), extending its U.S. patent protection and exclusivity until 20 ...

Core Insights - Boston Scientific Corporation (NYSE:BSX) is recognized as a leading AI-powered biotech stock, integrating artificial intelligence into its medical device portfolio, particularly in cardiology [1][4] - The FDA has expanded approval for the FARAPULSE system, which treats atrial fibrillation, a condition affecting nearly 60 million people globally [2] - The company combines internal R&D with strategic acquisitions and early-stage investments to rapidly commercialize AI-enhanced technologies across various medical divisions [3] Group 1: AI Integration and Product Development - Boston Scientific's AI strategy focuses on embedding advanced algorithms into revenue-generating devices like WATCHMAN and FARAPULSE, enhancing clinical outcomes [1] - The partnership with AI platforms such as Anumana aims to leverage data from millions of patients to improve diagnostics and treatment outcomes in electrophysiology and left atrial appendage closure (LAAC) procedures [2] - The company reported a strong organic sales growth of 17% year-over-year, with a notable 28% growth in its WATCHMAN device [4] Group 2: Future Milestones and Market Position - Key upcoming milestones include the commercialization of the Cortex OptiMap system combined with FARAPULSE and further AI-driven product launches [4] - The approach of combining internal R&D with strategic acquisitions supports the scalability of AI initiatives beyond cardiology into areas such as endoscopy and urology [3] - Boston Scientific's leadership in AI-enabled medical technology is reinforced through ongoing partnerships and product innovations [4]

Quipt Home Medical Corp. (NASDAQ:QIPT)  is among the best fundamentally strong penny stocks to buy right now. During the first quarter, Nuveen LLC acquired a new stake in Quipt Home Medical Corp. (NASDAQ:QIPT) through the purchase of 150,046 shares, valued at approximately $350,000. According to the recent disclosure with the SEC, the global asset management firm now owns nearly 0.35% of the company. We already know that Quipt Home Medical Corp. (NASDAQ:QIPT) is fueling its growth engine through strategic ...

MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company’s plan to strengthen its precision diagnostics portfolio. Earlier on August 5, 2025, MDxHealth SA (NASDAQ:MDXH) signed a definitive agreement for the takeover with payment structured over ...

Butterfly Network, Inc. (NYSE:BFLY) is among the best fundamentally strong penny stocks to buy right now. In the first quarter, Acadian Asset Management LLC raised its position in Butterfly Network, Inc. (NYSE:BFLY) by a whopping 270.5%. Following the purchase of 1,167,055 shares, the institutional investor now owns 1,598,552 shares of the company’s stock. With an ownership of 0.65%, the firm’s investment is worth $3,642,000. During its latest earnings call, the management highlighted that the second quar ...

Group 1 - The vulnerability of BDC dividends has increased due to the gradual relaxation of monetary tightness since March of this year [1] Group 2 - Roberts Berzins has over a decade of experience in financial management, focusing on shaping financial strategies for top-tier corporates and executing large-scale financings [2] - Significant efforts have been made by Roberts to institutionalize the REIT framework in Latvia, aimed at boosting the liquidity of pan-Baltic capital markets [2] - Policy-level contributions include the development of national SOE financing guidelines and frameworks for channeling private capital into affordable housing [2]

This top AI stock is up 75% since April.There are several great companies capitalizing on the artificial intelligence (AI) boom that would make solid stocks to buy right now. But among leading tech giants, Alphabet (GOOG 1.27%) (GOOGL 1.23%) stands out.The stock is up over 75% since hitting a 52-week low in April, but it still trades at a reasonable valuation. With 2 billion users and one of the best enterprise cloud services available, Alphabet is well-positioned to help investors outperform the market. Ho ...